Chinese Cohort Study of Coronary Heart Disease

Coronary Heart Diseases Clinical Trial

— CCS-CHD  

Official title:

Cross-Sectional Investigation of Secondary Prevention on Coronary Heart Disease and Generalization of Standardized Secondary Prevention in Chinese Coronary Heart Disease Patients

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT00745628
• Other study ID #: 2006BAI01A02-08
• Status: Recruiting
• Phase: N/A
• First received: September 2, 2008
• Last updated: September 2, 2008
• Start date: May 2008
• Est. completion date: December 2010

Study information

• Verified date: May 2008
• Source: Ministry of Science and Technology of the People´s Republic of China
• Contact: Tao Hong, MD
• Phone: 86-10-66551122
• Email: dr_hongtao[@]163.com
• Is FDA regulated: No
• Health authority: China: Ministry of Health
• Study type: Observational

Clinical Trial Summary

Construction of coronary heart disease cohort of more than 10000 patients in China. Investigation on current situation of secondary prevention of CHD will be carried out and the effect of physician training and patient education will be evaluated.

Description:

More than 40 hospitals of 16 provinces will enroll patients for this study. The study will include patients with diagnosed coronary heart disease. Investigators and all the physicians who will involve in daily care of CHD patients will have a brief training on guideline of secondary prevention in CHD and take a test on that. Questionnaires are used to evaluate patient's cognition of their diseases and knowledge on coronary heart disease. Patient education will be carried out during a 2 years follow up of all the patient enrolled before they are required to fill out another questionnaire. Physicians will also take a second test on secondary prevention of CHD at that time. Patients will take blood lipids and glucose test according to their physician's requirement.The effect of physician training and patient education will be evaluated by comparing the results of questionnaires and tests at the beginning of the study and in the end of the 2 years follow up.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 10000
• Est. completion date: December 2010
• Est. primary completion date: December 2010
• Accepts healthy volunteers: No
• Gender: Both
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Diagnosed coronary heart disease

• Confirmed by coronary angiography;

• Diagnosed myocardial infarction;

• Typical symptom of ischemic chest pain with positive stress test;

• Willing to sign an inform consent.

Exclusion Criteria

• Patients won't sign an inform consent or will not comply with the follow up.

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Coronary Artery Disease
• Coronary Disease
• Coronary Heart Diseases
• Heart Diseases
• Myocardial Ischemia

Locations

Country	Name	City	State
China	Peking University First Hospital	Beijing	Beijing

Sponsors (1)

Lead Sponsor	Collaborator
Ministry of Science and Technology of the People´s Republic of China

Country where clinical trial is conducted

China,